https://www.selleckchem.com/products/ml385.html
Studies providing Alzheimer's disease (AD) prevalence data have largely neglected to characterize the proportion of AD that is mild, moderate, or severe. Estimates of the severity distribution along the AD continuum, including the mild cognitive impairment (MCI) stage, are important to plan research and allocate future resources, particularly resources targeted at particular stages of disease. To characterize the distribution of severity of AD dementia and MCI among prevalent cases in the population-based Framingham Heart Study. Participa
Like
Comment
Share
